ADDIS ABABA: Ethiopia’s Federal Technical and Vocational Education and Training Institute and China’s Tianjin University of Technology and Education have formalized a new level of cooperation aimed at advancing technical and vocational education throu…
Month: October 2024
Technology Instrumental in Managing Ethiopia’s Land and Water Resources: Minister
ADDIS ABABA: Technology application is crucial for managing Ethiopia’s land and water resources, as emphasized by Minister of Water and Energy Habtamu Itefa. A meeting organized in Addis Ababa by the Ministry of Water and Energy highlighted the role o…
Renovated Africa Hall in Addis Ababa Becomes Hub for Research and Tourism
ADDIS ABABA: The newly renovated Africa Hall in Addis Ababa has emerged as a significant research center and tourism destination, highlighting Africa’s rich history and diverse art. The transformation is expected to benefit not only Ethiopia but also …
CAF Executive Committee Member Backs Ethiopia’s Bid to Host 2029 AFCON
ADDIS ABABA: A member of the Confederation of African Football (CAF) Executive Committee, Maclean Letshwiti, has expressed strong confidence in Ethiopia’s ability to host the 2029 Africa Cup of Nations (AFCON). Letshwiti, who is also the former Presid…
La plateforme Quantexa reconnue leader de sa catégorie dans le RiskTech Quadrant® pour ses solutions de connaissance du client
La plateforme Quantexa a obtenu une place de choix dans le rapport RiskTech100® 2025, soulignant ainsi sa force et son innovation sur le marché en expansion de la technologie des risques et de la conformité LONDRES, 22 oct. 2024 (GLOBE NEWSWIRE) — La plateforme Quantexa, l’un des principaux fournisseurs de solutions d’intelligence décisionnelle pour les […]
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks catalytic activity of the toxin’s innate glucosyltransferase in order to inhibit the toxin produced by C. diff. in the gastrointestinal tract. There are up to 175,000 cases of recurrent C. diff. each […]